active · ANR — ANR-22-CE29-0026
DREAMY — Early steps of amyloid peptide self-assembly
A joint NMR × molecular-modelling consortium deciphering the earliest oligomeric steps of amyloid-β self-assembly, using a lanthanide-based crystallophore (Xo4) as a local probe and perturbant.
Also presented by the eDIAM team, Institut de Chimie de Nice
DREAMY — DecipheRing Early steps of self-assembly of AMYloid forming peptides (ANR-22-CE29-0026) — brings together solution NMR and atomistic molecular modelling to capture the earliest, transient oligomers that form on the pathway to amyloid fibrils. The eDIAM contribution focuses on the modelling side: enhanced-sampling molecular dynamics of amyloid-β peptide variants, characterisation of the initial peptide–peptide contacts, and rationalisation of how a lanthanide-based crystallophore (Xo4) perturbs and reports on the assembly process.
By cross-validating NMR observables against simulated ensembles, the project aims to deliver a residue-level picture of the nucleation events that current biophysical methods cannot resolve directly — a prerequisite for designing molecules that intercept amyloidogenic peptides before fibril formation.